Charles River Laboratories International Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $2.61B | $241.9M |
| Jun 2022 | — | $2.65B | $200.3M |
| Sep 2022 | — | $2.63B | $193.7M |
| Dec 2022 | — | $2.98B | $233.9M |
| Apr 2023 | — | $3.11B | $201.6M |
| Jul 2023 | — | $3.25B | $200.4M |
| Sep 2023 | — | $3.31B | $157.2M |
| Dec 2023 | — | $3.60B | $276.8M |
| Mar 2024 | — | $3.64B | $327.0M |
| Jun 2024 | — | $3.72B | $179.2M |
| Sep 2024 | — | $3.78B | $210.2M |
| Dec 2024 | — | $3.46B | $194.6M |
| Mar 2025 | — | $3.19B | $229.4M |
| Jun 2025 | — | $3.35B | $182.8M |
| Sep 2025 | — | $3.41B | $207.1M |
| Dec 2025 | — | $3.16B | $213.8M |
| Mar 2026 | — | $2.94B | $191.8M |
| Jun 2026 | — | $2.84B | $192.0M |